Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 May 2016 07:00

RNS Number : 3997Y
Tarsus Group PLC
17 May 2016
 

17 May 2016

 

Tarsus Group plc

Trading Update

Tarsus Group plc (LSE: TRS, "Tarsus" or the "Group"), the international business-to-business media group, is today providing a trading update on its current financial year to date.

Trading since the publication of the Annual Results on 2 March 2016 has been in-line with Board expectations with good performances to date across the Group's portfolio. Buyer growth on a like-for-like basis is tracking ahead of our internal target of 5%. We continue to execute our "Quickening the Pace" strategy and, as part of this, remain on course to run a larger number of replications in 2016.

Forward bookings for the full year are tracking 10%+ ahead on a like-for-like basis.

Emerging Markets

China continues to perform well with SIUF, Asia's largest underwear show, exceeding the 2015 edition. Buyer growth was up an excellent 13%.

Trading in Turkey was in-line with expectations with a particularly strong performance from Ideal Homex, the largest event in the period.

The Dubai portfolio continues to demonstrate growth. The largest event in the first half of the year was GESS (education), which performed very well with buyers increasing 17% over the previous edition.

Plastimagen, our plastics exhibition in Mexico, performed strongly. The replication of GESS into Mexico held its second edition and showed good progress, with buyer growth of 8%.

United States

The US portfolio continues to show solid growth. Our Medical business performed in line with expectations. This division continues to make good progress with its growth initiatives, with Painweek performing particularly well.

Douglas Emslie, Tarsus Group Managing Director, said:

"The Group has seen encouraging performances from its exhibitions so far this year in what is the quietest period in our two-year cycle and has strong forward bookings. Tarsus remains focused on delivering industry-leading buyer growth to its exhibitions and continues to invest in replicating its leading brands to accelerate growth in the medium term.

"We are mindful of the current global macroeconomic uncertainty and geopolitical risk and have budgeted accordingly. We remain positive about our trading prospects for 2016 and have a strong bookings position for our larger 2017 biennial events."

The Group plans to announce its Interim Results for the six months ended 30 June 2016 on 27 July 2016.

 

For further information:

 

Tarsus Group plc:

 

Douglas Emslie, Group Managing Director

+44 (0) 20 8846 2700

Dan O'Brien, Group Finance Director

Neville Harris, Investor Relations

+44 (0)7909 976044

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUGGAUPQGMQ
Date   Source Headline
16th May 20197:00 amRNSTrading Update
9th May 20196:19 pmRNSBlock Listing Six Monthly Return
30th Apr 201910:14 amRNSTotal Voting Rights
16th Apr 20192:40 pmRNSDirector/PDMR Shareholding
2nd Apr 20193:43 pmRNSBlock listing Interim Review
1st Apr 201910:44 amRNSTotal Voting Rights
19th Mar 201911:42 amRNS2018 Annual Report
8th Mar 20194:36 pmRNSPrice Monitoring Extension
27th Feb 20197:00 amRNSFinal Results
6th Feb 20194:35 pmRNSPrice Monitoring Extension
31st Jan 201911:53 amRNSTotal Voting Rights
30th Jan 20197:00 amRNSOption agreement re Tarsus Connect
16th Jan 20194:22 pmRNSApplication for Admission
14th Jan 20197:00 amRNSYear-end Trading Update
13th Dec 20184:48 pmRNSScrip Dividend Circular (the "Circular")
30th Nov 20183:10 pmRNSTotal Voting Rights
20th Nov 20181:44 pmRNSApplication for Admission
6th Nov 20187:00 amRNSCapital Markets Seminar and Trading Update
1st Nov 20182:56 pmRNSTotal Voting Rights
18th Sep 20186:20 pmRNSDirector/PDMR Shareholding
14th Sep 201812:06 pmRNSResults of Placing
14th Sep 20187:00 amRNSAcquisitions and Placing of New Ordinary Shares
10th Sep 20183:18 pmRNSBlock Listing Six Monthly Return
31st Aug 20183:39 pmRNSTotal Voting Rights
24th Aug 201811:17 amRNSHalf-year Report
1st Aug 201811:54 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSHalf-year Report
13th Jul 20182:34 pmRNSApplication for Admission - scrip dividend shares
13th Jul 20182:18 pmRNSDirector Declaration
21st Jun 20181:52 pmRNSResult of AGM
18th Jun 20183:37 pmRNSHolding(s) in Company
12th Jun 20184:41 pmRNSDirector/PDMR Shareholding
8th Jun 20183:45 pmRNSScrip Dividend Circular
1st Jun 201812:31 pmRNSTotal Voting Rights
21st May 20186:10 pmRNSNotice of AGM
17th May 20187:00 amRNSTrading Update
9th May 20187:00 amRNSBoard Changes
9th May 20187:00 amRNSBlock Listing Six Monthly Return
1st May 201811:45 amRNSTotal Voting Rights and Capital
20th Apr 201812:15 pmRNSDirector/PDMR Shareholding
20th Apr 201812:14 pmRNSDirector/PDMR Shareholding
18th Apr 20184:29 pmRNSNotification of Transactions
29th Mar 201810:50 amRNSTotal Voting Rights
22nd Mar 20185:01 pmRNS2017 Annual Report
9th Mar 20183:54 pmRNSDirector/PDMR Shareholding
6th Mar 201810:18 amRNSBlock Listing Six Monthly Return
5th Mar 20185:06 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSFinal Results
31st Jan 20189:40 amRNSTotal Voting Rights
12th Jan 201810:30 amRNSApplication for Admission - scrip dividend shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.